Staff20152016201720182019
Personnel at the end of the year122,966122,985126,457125,161103,914
Staff turnover in EUR363,022356,197350,637374,402412,706
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20152016201720182019
Shares outstanding (in mn.)991.00972.00969.002,265.01936.00
Dividend per share2.62.72.752.82.85
Basic earnings per share7.402.823.285.445.12
P/L in EUR million under IAS/IFRS20152016201720182019
Turnover49,440.048,518.049,109.051,900.047,498.0
Operating income (EBIT)7,344.27,058.08,125.212,491.68,071.9
Earnings before taxes8,134.07,817.08,999.013,835.08,940.0
Annual net profit/ loss17,783.06,712.07,703.012,614.011,737.0
Balance sheet in EUR million under IAS/IFRS20152016201720182019
Assets
Total current assets22,845.024,931.028,208.034,756.028,663.0
Total fixed assets108,711.0105,193.0104,871.0110,000.088,866.0
Total assets131,556.0130,124.0133,079.0145,563.0118,370.0
Liabilities
Total short-term liabilities23,708.022,209.023,403.029,607.028,264.0
Total long-term liabilities30,726.033,024.035,449.037,264.034,555.0
Total provisions0.00.00.00.00.0
Equity capital77,046.074,832.074,168.078,614.055,474.0
Total liabilities131,556.0130,124.0133,079.0145,563.0118,370.0
Management:
Vasant Narasimhan, M.D.
Steven Baert
Shannon Thyme Klinger
Robert Weltevreden
Richard Saynor
Marie-France Tschudin
John Tsai
Harry Kirsch
Bertrand Bodson
Susanne Schaffert
Steffen Lang
Klaus Moosmayer
James E. Bradner
Board:
William T. Winters
Ton Buechner
Simon Moroney
Patrice Bula
Frans van Houten
Elizabeth Doherty
Charles L. Sawyers
Bridgette Heller
Ann Fudge
Srikant Datar
Nancy C. Andrews
Enrico Vanni
Charlotte Pamer-Wieser
Andreas von Planta
Joerg Reinhardt
Shareholding in %:
Emasan AG 3.5
Novartis Foundation for Employee Participation 2.1
UBS Fund Management 2.1
free float 92.3
Address: Lichtstrasse, CH-4002 Basel
T: +41-61-324-1111
F: +41-61-324-8001
I: http://www.novartis.com
E: investor.relations@novartis.com